Stock CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector ratings Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
 04:00:02 2024-09-09 pm EDT 		5-day change 1st Jan Change
188.16 USD +0.11% Intraday chart for Charles River Laboratories International, Inc. -4.85% -20.41%
Sep. 05 Transcript : Charles River Laboratories International, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 09:15 AM
Sep. 04 Charles River Laboratories, Insightec Collaborate on Focused Ultrasound in Neuroscience MT
Main competitors
Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Composite Fundamentals Composite Valuation Composite Consensus Composite Momentum Composite Visibility Investor Rating ESG Refinitiv Capi. ($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
C+
9.7B
LONZA GROUP AG Stock Lonza Group AG
A
46.02B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
B
44.31B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 -
B
31.68B
CELLTRION, INC. Stock Celltrion, Inc.
C
29.63B
MODERNA, INC. Stock Moderna, Inc.
 -
B-
28.02B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
B-
25.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
B+
15.38B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
B+
11.34B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
C+
10.39B
QIAGEN N.V. Stock Qiagen N.V.
A
9.89B
REVOLUTION MEDICINES, INC. Stock Revolution Medicines, Inc.
 -
C-
6.99B
IONIS PHARMACEUTICALS, INC. Stock Ionis Pharmaceuticals, Inc.
 -
B+
6.86B
BACHEM HOLDING AG Stock Bachem Holding AG
B-
6.7B
HANGZHOU TIGERMED CONSULTING CO., LTD Stock Hangzhou Tigermed Consulting Co., Ltd
B+
5.51B
BLUEPRINT MEDICINES CORPORATION Stock Blueprint Medicines Corporation
B-
5.47B
ALKERMES PLC Stock Alkermes plc
B
4.42B
Average
B
 17.49B
Weighted average by Cap.
B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CRL Stock
  4. Sector Charles River Laboratories International, Inc.
  5. Sector ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW